Latigo Biotherapeutics, Inc. · NASDAQ:LTGO
Latigo Biotherapeutics, Inc. shareholders
As of Sep 30, 2026, 55 institutions reported holding Latigo Biotherapeutics, Inc., 63.0% of its shares. Largest: 5AM Venture Management, LLC, Ra Capital Management, L.P. and Deep Track Capital, LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Latigo Biotherapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| 5AM Venture Management, LLC | 7.33M | 11.0% | new | Nov 16, 2026 |
| Ra Capital Management, L.P. | 5.3M | 8.0% | new | Nov 16, 2026 |
| Deep Track Capital, LP | 4.41M | 6.6% | new | Nov 16, 2026 |
| Blue Owl Capital Holdings LP | 3.6M | 5.4% | new | Nov 13, 2026 |
| Foresite Capital Management V, LLC | 3.56M | 5.4% | new | Nov 16, 2026 |
| Fidelity | 2.88M | 4.3% | new | Nov 10, 2026 |
| Foresite Capital Management VI LLC | 2.2M | 3.3% | new | Nov 16, 2026 |
| Cormorant Asset Management, LP | 1.82M | 2.7% | new | Nov 16, 2026 |
| Orbimed Advisors LLC | 1.68M | 2.5% | new | Nov 16, 2026 |
| Vanguard | 1M | 1.5% | new | Nov 13, 2026 |